Compare Bristol-Myers Squibb Co (BMY) vs Vale SA (VALE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bristol-Myers Squibb Co vs Vale SA — how do they compare? Bristol-Myers Squibb Co trades at $63.41 (market cap $129.94B), while Vale SA trades at $14.39 (market cap $61.97B). The key difference: Bristol-Myers Squibb Co is far larger — about 2.1× Vale SA's market cap, and Vale SA pays the higher dividend (8.35%). Which is the better fit depends on your goals.
| BMY | VALE | |
|---|---|---|
Market Cap | $129.94B | $61.97B |
Sector | Health | Basic Materials |
52-Week High | $65.89 | $17.82 |
52-Week Low | $42.60 | $9.71 |
Enterprise Value | $163.92B | $78.22B |
Dividend Yield | 3.96% | 8.35% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Bristol-Myers Squibb Co
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
Read more on BMY →About Vale SA
Vale is the world's largest iron ore miner and one of the largest diversified miners, along with BHP and Rio Tinto. Earnings are dominated by the bulk materials division, primarily iron ore and iron ore pellets, with minor contributions from iron ore proxies, including manganese and coal. The base metals division is much smaller, primarily consisting of nickel mines and smelters with a small contribution from copper.
Read more on VALE →
